The real-world clinical study based on the specialized database of multiple myeloma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400081476

Enrollment

Unknown

Registered

2024-03-01

Start date

2023-01-01

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple myeloma

Interventions

patients with multiple myeloma:None

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients who are diagnosed as multiple myeloma in West China Hospital, Sichuan University.

Exclusion criteria

Exclusion criteria: 1. Patients complicated with other tumors. 2. Patients with incomplete data at baseline 3. Patients with no follows

Design outcomes

Primary

Measure	Time frame
renal function;survival;treatment efficacy;	—

Countries

China

Contacts

Public ContactTing Niu

West China Hospital, Sichuan University.

tingniu@sina.com+86 189 8060 1242

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026